Final rule 2025-24123
Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.
Source-supplied record
Document details
- Document number
- 2025-24123
- Published
- Dec 31, 2025
- Effective
- Jan 1, 2026
- Comments close
- Not supplied
- Federal Register citation
- 90 FR 61301
Docket identifiers
- Docket No. DEA-407
CFR references
- Title 21, part 1307
- Title 42, part 12